Anna Codina Selected Research

Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)

1/2020

Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Codina Research Topics

Disease

3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2023 - 01/2023
2	Muscle Weakness 10/2023 - 01/2023
2	COVID-19 01/2022 - 01/2022
1	Intellectual Disability (Idiocy) 10/2023
1	Movement Disorders (Movement Disorder) 10/2023
1	Disease Progression 03/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Muscular Dystrophies (Muscular Dystrophy) 01/2023
1	Rhabdomyolysis 01/2023
1	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2020
1	Scoliosis 01/2020
1	Epilepsy (Aura) 01/2020

Drug/Important Bio-Agent (IBA)

2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023 - 01/2023
2	DystrophinIBA 03/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
1	dystrobrevinIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	nusinersenIBA 01/2023
1	CytokinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2020
1	Laminin (Merosin)IBA 01/2020